These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Acceptance, efficacy, and side effects of Norplant implants in four counties in north China. Tu P; Qiu S; Fang H; Smith HL Stud Fam Plann; 1997 Jun; 28(2):122-31. PubMed ID: 9216032 [TBL] [Abstract][Full Text] [Related]
44. Experience of Finnish women with Norplant insertions and removals. Ollila E; Sihvo S; Meriläinen J; Hemminki E Br J Obstet Gynaecol; 1997 Apr; 104(4):488-94. PubMed ID: 9141587 [TBL] [Abstract][Full Text] [Related]
45. The timing of norplant insertion and postpartum depression in teenagers. Stevens-Simon C; Kelly L; Wallis J J Adolesc Health; 2000 Jun; 26(6):408-13. PubMed ID: 10822182 [TBL] [Abstract][Full Text] [Related]
46. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users. Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486 [TBL] [Abstract][Full Text] [Related]
47. [Clinical experience with 7 years of norplant]. Huang S; Gu S Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):674-6. PubMed ID: 11479951 [TBL] [Abstract][Full Text] [Related]
48. NORPLANT contraceptive implants advancing. Segal SJ Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797 [TBL] [Abstract][Full Text] [Related]
49. Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant). A prospective study in Belgium. Vekemans M; Delvigne A; Paesmans M Contraception; 1997 Nov; 56(5):291-9. PubMed ID: 9437557 [TBL] [Abstract][Full Text] [Related]
50. Norplant-2 subdermal contraceptive system: experience in Taiwan. Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598 [TBL] [Abstract][Full Text] [Related]
51. A longitudinal study of changes in endometrial microvascular density in Norplant implant users. Hickey M; Simbar M; Young L; Markham R; Russell P; Fraser IS Contraception; 1999 Feb; 59(2):123-9. PubMed ID: 10361627 [TBL] [Abstract][Full Text] [Related]
52. Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health. International Collaborative Post-Marketing Surveillance of Norplant Contraception; 2001 Apr; 63(4):167-86. PubMed ID: 11376646 [TBL] [Abstract][Full Text] [Related]
54. Experience with side effects and health risks associated with Norplant implant use in adolescents. Rosenthal SL; Biro FM; Kollar LM; Hillard PJ; Rauh JL Contraception; 1995 Nov; 52(5):283-5. PubMed ID: 8585884 [TBL] [Abstract][Full Text] [Related]
55. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study. Hickey M; Fraser I; Dwarte D; Graham S Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744 [TBL] [Abstract][Full Text] [Related]
56. Norplant contraceptive subdermal implants: one year experience in Singapore. Singh K; Viegas OA; Ratnam SS Contraception; 1988 May; 37(5):457-69. PubMed ID: 3136971 [TBL] [Abstract][Full Text] [Related]
57. Norplant implants in Ethiopia. Argina H; Lukman HY East Afr Med J; 1997 Apr; 74(4):258-62. PubMed ID: 9299831 [TBL] [Abstract][Full Text] [Related]
58. Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception. Darney PD; Callegari LS; Swift A; Atkinson ES; Robert AM Am J Obstet Gynecol; 1999 Apr; 180(4):929-37. PubMed ID: 10203661 [TBL] [Abstract][Full Text] [Related]
59. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users. Pasquale SA; Knuppel RA; Owens AG; Bachmann GA Contraception; 1994 Aug; 50(2):109-16. PubMed ID: 7956210 [TBL] [Abstract][Full Text] [Related]